Dr. Eileen Engle, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 847 Easton Road, Suite 2300, Warrington, PA 18976 Phone: 215-918-5727 Fax: 215-918-5729 |
News Archive
The invasive and expensive diagnosis process of bladder cancer, which is one of the most common and aggressive cancers in the United States, may be soon helped by a novel non-invasive diagnostic method thanks to advances in machine learning research at the San Diego Supercomputer Center, Moores Cancer Center, and CureMatch Incorporated.
QLT Inc. today announced that final results from the Novartis-sponsored Phase IIIb DENALI study were presented on June 8, 2010 during the World Ophthalmology Congress in Berlin. DENALI was a 24-month randomized, double-masked, multicenter trial in patients with subfoveal choroidal neovascularization secondary to wet age-related macular degeneration (all lesion types).
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
A new switch that enables Salmonella bacteria to sabotage host cells is revealed in a study published today in the journal Science.
› Verified 3 days ago